Upper Airway Inflammation and Olfaction: Mechanisms of Loss and Recovery
Recruiting now · Not applicable
Conditions studied: Chronic Rhinosinusitis With Nasal Polyps (CRSwNP)
In brief
The goal of this clinical trial is to understand the mechanisms leading to olfactory dysfunction (OD) in chronic rhinosinusitis (CRS). The main questions it aims to answer are: * Is the type 2 inflammation impacting the olfactory epithelium regeneration, leading to OD? * Does a treatment interfering with one of the major T2 inflammatory cytokines, have an impact on the mechanisms of OD in CRS? Participants will undergo olfactory testing and nasal brushing before and after 3 months of treatment.
Key facts
- Study ID
- NCT06776042
- Run by
- Cliniques universitaires Saint-Luc- Université Catholique de Louvain
- People needed
- 140
- Starts
- 2023-05-22
- Expected to finish
- 2026-09-30
- Last updated by the study team
- 2026-04-27
Who can join
Age: 18 and older, up to 70. Sex: any. Healthy volunteers: accepted.
You may qualify if…
- At least two of the following symptoms: nasal obstruction, rhinorrhoea, smell loss, facial pain for 12 weeks.
- Endoscopic visualisation of bilateral sinonasal polyps
- SSI (TDI) < 30.75 and decreased sense of smell subjectively
- Eosinophilia > 300/μl of blood Ku/l
- On a stable nasal steroid treatment for at least 4 weeks
You may not qualify if…
- Active smoking
- Primary and secondary immune deficiencies
- Ciliary diseases (cystic fibrosis, primary ciliary diskinesia)
- History of or current nasal malignancies
- < 18 years and > 70 years
- Patients unable to express consent
- Use of systemic corticosteroids for < 4 weeks before visit 1 • Use of systemic or local antibiotics for < 4 weeks before visit 1
Where it is running
- Cliniques Universitaires Saint-Luc — Brussels, Belgium (enrolling)
Full record on ClinicalTrials.gov
Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.